Literature DB >> 9482552

A case/control study of risk factors for major salivary gland cancer.

J E Muscat1, E L Wynder.   

Abstract

BACKGROUND: Salivary gland cancer (SGC) is a rare disease with a largely unknown origin. Because cancer of the tongue and mouth floor is caused primarily by smoking and alcohol consumption, we investigated the role of tobacco, alcohol, and other possible risk factors in the development of SGC in a hospital-based study.
METHODS: Interviews were obtained from 128 patients with newly diagnosed histologically confirmed SGC and from 114 age- and gender-matched controls by using a structured questionnaire. All patients were interviewed at bedside by a trained interviewer.
RESULTS: No differences in levels of education were found between the two groups. Cigarette smoking and alcohol consumption did not independently or jointly increase the risk of SGC. Chewing tobacco and snuff use were also unrelated factors. The odds ratio for low body mass in men was 0.46 (p = 0.05). There was no relation with body mass in women. An examination of employment history and job-related exposures revealed no occupational risk factors.
CONCLUSION: These findings show that smoking, alcohol consumption, and most occupational exposures are unrelated to SGC.

Entities:  

Mesh:

Year:  1998        PMID: 9482552     DOI: 10.1016/S0194-5998(98)80013-2

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

1.  Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma.

Authors:  Li Xu; Phi C Doan; Qingyi Wei; Guojun Li; Erich M Sturgis
Journal:  Oral Oncol       Date:  2012-04-12       Impact factor: 5.337

Review 2.  Systematic review of the relation between smokeless tobacco and cancer in Europe and North America.

Authors:  Peter N Lee; Jan Hamling
Journal:  BMC Med       Date:  2009-07-29       Impact factor: 8.775

3.  Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.

Authors:  Li Xu; Hongwei Tang; Diane W Chen; Adel K El-Naggar; Peng Wei; Erich M Sturgis
Journal:  Cancer       Date:  2015-03-30       Impact factor: 6.860

4.  Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

Authors:  Houda Boukheris; Rochelle E Curtis; Charles E Land; Graça M Dores
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

5.  Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Houda Boukheris; Marilyn Stovall; Ethel S Gilbert; Kayla L Stratton; Susan A Smith; Rita Weathers; Sue Hammond; Ann C Mertens; Sarah S Donaldson; Gregory T Armstrong; Leslie L Robison; Joseph P Neglia; Peter D Inskip
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-24       Impact factor: 7.038

6.  Alcohol and cancer. Still no clear evidence to link specific beverages to specific cancers.

Authors:  S Sabroe
Journal:  BMJ       Date:  1998-09-26

7.  Early detection in head and neck cancer - current state and future perspectives.

Authors:  Andreas O H Gerstner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2010-10-07

Review 8.  Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis.

Authors:  Giulio Cantù
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-06       Impact factor: 2.124

Review 9.  Salivary gland neoplasms.

Authors:  Terry A Day; John Deveikis; M Boyd Gillespie; John K Joe; Besim Ogretmen; J David Osguthorpe; Susan G Reed; Mary S Richardson; Michael Rossi; Ranjiv Saini; Anand K Sharma; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2004-02

10.  Meta-analysis of the relation between European and American smokeless tobacco and oral cancer.

Authors:  Rolf Weitkunat; Edward Sanders; Peter N Lee
Journal:  BMC Public Health       Date:  2007-11-15       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.